263 related articles for article (PubMed ID: 2410114)
1. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
2. Current status and strategies for vaccines against diseases induced by human T-cell lymphotropic retroviruses (HTLV-I, -II, -III).
Fischinger PJ; Robey WG; Koprowski H; Gallo RC; Bolognesi DP
Cancer Res; 1985 Sep; 45(9 Suppl):4694s-4699s. PubMed ID: 2410115
[TBL] [Abstract][Full Text] [Related]
3. Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.
Miyazawa M; Fujisawa R; Ishihara C; Takei YA; Shimizu T; Uenishi H; Yamagishi H; Kuribayashi K
J Immunol; 1995 Jul; 155(2):748-58. PubMed ID: 7541823
[TBL] [Abstract][Full Text] [Related]
4. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
5. Immunoprotective determinants in friend murine leukemia virus envelope protein.
Hasenkrug KJ; Brooks DM; Robertson MN; Srinivas RV; Chesebro B
Virology; 1998 Aug; 248(1):66-73. PubMed ID: 9705256
[TBL] [Abstract][Full Text] [Related]
6. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
7. An overview of the HTLV Symposium and reflections about the past, present, and future.
Gross L
Cancer Res; 1985 Sep; 45(9 Suppl):4706s-4709s. PubMed ID: 2861897
[No Abstract] [Full Text] [Related]
8. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
9. Feline leukemia virus envelope glycoprotein vaccine: preparation and evaluation of immunizing potency in guinea pig and cat.
Salerno RA; Lehman ED; Larson VM; Hilleman MR
J Natl Cancer Inst; 1978 Dec; 61(6):1487-93. PubMed ID: 214605
[No Abstract] [Full Text] [Related]
10. Prospects for treatment of human retrovirus-associated diseases.
Bolognesi DP; Fischinger PJ
Cancer Res; 1985 Sep; 45(9 Suppl):4700s-4705s. PubMed ID: 2410116
[TBL] [Abstract][Full Text] [Related]
11. Different H-2 subregions influence immunization against retrovirus and immunosuppression.
Morrison RP; Earl PL; Nishio J; Lodmell DL; Moss B; Chesebro B
Nature; 1987 Oct 22-28; 329(6141):729-32. PubMed ID: 2823142
[TBL] [Abstract][Full Text] [Related]
12. Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection.
Dittmer U; Brooks DM; Hasenkrug KJ
Nat Med; 1999 Feb; 5(2):189-93. PubMed ID: 9930867
[TBL] [Abstract][Full Text] [Related]
13. Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge.
Langhammer S; Hübner J; Jarrett O; Kurth R; Denner J
Antiviral Res; 2011 Jan; 89(1):119-23. PubMed ID: 21108970
[TBL] [Abstract][Full Text] [Related]
14. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
15. [Quantitation of and neutralizing antibodies to AIDS-retroviruses; a novel system using HTLV-I carrying MT-4 cells].
Harada S; Yamamoto N
Tanpakushitsu Kakusan Koso; 1985 Dec; 30(13):1394-407. PubMed ID: 3003812
[No Abstract] [Full Text] [Related]
16. Structural and epidemiological features of primate lymphotropic retroviruses.
Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N
Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632
[TBL] [Abstract][Full Text] [Related]
17. The prospects for and pathways toward a vaccine for AIDS.
Francis DP; Petricciani JC
N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against feline retroviruses.
Jarrett O
Dev Biol Stand; 1990; 72():185-8. PubMed ID: 2178114
[No Abstract] [Full Text] [Related]
19. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccine against Friend erythroleukaemia virus.
Síma P; Smahel M; Jelínek F; Vonka V
Folia Biol (Praha); 2002; 48(2):43-50. PubMed ID: 12002674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
